Equities

Standard Chem & Pharm Co Ltd

1720:TAI

Standard Chem & Pharm Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (TWD)77.40
  • Today's Change4.20 / 5.74%
  • Shares traded2.90m
  • 1 Year change+16.74%
  • Beta--
Data delayed at least 20 minutes, as of Jul 23 2024.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Standard Chem & Pharm Co Ltd is a Taiwan-based company principally engaged in the manufacture and sales of western pharmaceuticals, dietary supplement and active pharmaceutical ingredients. The Company’s products cover circulatory system drugs, digestive system drugs, respiratory system drugs, nervous system drugs, metabolic drugs and general foods and health foods. The Company is also engaged in the sales of medical equipment, animal medicine, cosmetics and milk powder. The Company's products are sold to domestic and overseas markets.

  • Revenue in TWD (TTM)6.36bn
  • Net income in TWD876.61m
  • Incorporated1967
  • Employees1.13k
  • Location
    Standard Chem & Pharm Co LtdNo.6-20Tuku, Tuku Village, Sinying DistrictTAINAN 730TaiwanTWN
  • Phone+886 66361516
  • Fax+886 66352817
  • Websitehttps://www.standard.com.tw/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Panion & BF Biotech Inc1.97bn98.39m8.34bn321.0084.834.5530.954.231.151.1523.0021.360.63371.6610.01--3.164.084.775.6352.5452.374.995.930.79786.410.2726111.06-21.545.96-57.65-13.4735.39-3.23
SCI Pharmtech Inc1.17bn275.79m10.94bn241.0037.572.1324.839.332.442.4412.2043.030.19681.524.62--4.636.905.238.2627.2338.1823.5319.852.8435.670.166942.3833.83-9.10-4.55-8.0044.67-16.35
Adimmune Corp1.66bn-574.85m12.67bn564.00--2.34--7.64-1.36-1.363.9412.590.17961.733.53---7.590.6867-9.230.773924.1430.11-42.273.042.06-25.640.359532.80-20.7216.77-319.91--38.05--
Formosa Laboratories Inc4.56bn55.39m13.23bn480.00245.951.7732.082.900.44720.447237.8562.120.35181.525.26---0.63492.68-0.85923.6145.0135.40-1.808.751.180.7450.326627.3815.8010.16-69.16-6.52-11.6032.22
Standard Chem & Pharm Co Ltd6.36bn876.61m13.83bn1.13k15.792.618.832.174.904.9035.5629.660.56362.296.26--10.709.6821.7217.6143.3843.7518.9917.021.32--0.127660.346.6411.802.3917.4029.9712.47
YungShin Global Holding Corp7.15bn922.44m14.55bn1.57k15.772.0711.462.033.463.4626.8526.370.62241.505.53--8.566.6412.1810.2042.7345.1113.7610.451.33--0.110970.94-3.88-1.33-1.403.34-29.000.893
Data as of Jul 23 2024. Currency figures normalised to Standard Chem & Pharm Co Ltd's reporting currency: Taiwan Dollar TWD

Institutional shareholders

1.01%Per cent of shares held by top holders
HolderShares% Held
Dimensional Fund Advisors LPas of 04 Jul 20241.29m0.72%
Mellon Investments Corp.as of 03 Jul 2024260.00k0.15%
Dimensional Fund Advisors Ltd.as of 31 May 202484.05k0.05%
SSgA Funds Management, Inc.as of 03 Jul 202461.00k0.03%
Franklin Templeton SinoAm Securities Investment Mgmt, Incas of 05 Jul 202435.00k0.02%
DFA Australia Ltd.as of 31 May 202432.00k0.02%
American Century Investment Management, Inc.as of 03 Jul 202419.00k0.01%
LGT Capital Partners AG (Investment Management)as of 30 Nov 202313.00k0.01%
Irish Life Investment Managers Ltd.as of 04 Jul 20246.45k0.00%
CI Investments, Inc.as of 31 Dec 20234.15k0.00%
More ▼
Data from 31 Mar 2024 - 18 Jul 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.